Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Evidence is insufficient to show that combined treatment increases mortality.
作者信息
Aaltonen H, Kilkku O, Heinonen E, Mäki-Ikola O
出版信息
BMJ. 1998 Dec 5;317(7172):1586-7.
PMID:9890764
Abstract
摘要
相似文献
1
2
3
Selegiline: a second look. Six years later: too risky in Parkinson's disease.司来吉兰：再审视。六年后：对帕金森病风险过高。
Prescrire Int. 2002 Aug;11(60):108-11.
4
Treatment of Parkinson's disease.帕金森病的治疗
Curr Opin Neurol Neurosurg. 1993 Jun;6(3):339-43.
5
Clinical inquiries. What is the best initial treatment of Parkinson's disease?临床咨询。帕金森病的最佳初始治疗方法是什么？
J Fam Pract. 2003 Nov;52(11):897-9.
6
Treatment of Parkinson's disease. From theory to practice.帕金森病的治疗。从理论到实践。
Postgrad Med. 1994 Apr;95(5):52-4, 57-8, 61-4 passim.
7
Deprenyl and levodopa and Parkinson's disease progression.司来吉兰、左旋多巴与帕金森病进展
Ann Neurol. 1996 Aug;40(2):267-8. doi: 10.1002/ana.410400228.
8
Moderate Parkinson's disease. Strategies for maximizing treatment.中度帕金森病。优化治疗的策略。
Postgrad Med. 1996 Jan;99(1):52-4, 61-3, 67-8, passim.
9
Selegiline for Parkinson's disease.司来吉兰用于帕金森病。
Am Fam Physician. 1990 Feb;41(2):589-91.
10
Treatment of Parkinson's disease.帕金森病的治疗。
Aust Fam Physician. 1995 Sep;24(9):1685-7, 1690-2.
Zotero 插件